Results 221 to 230 of about 280,543 (339)
Estrone‐α‐2DG, synthesized via a one‐pot multi‐enzyme system, selectively inhibits aromatase (IC50 = 0.101μM) and triple negative breast cancer cells (IC50 = 20.46 μM), offering a dual function therapeutic scaffold. ABSTRACT Aromatase inhibitors (AIs) are vital in the treatment of estrogen‐dependent breast cancer, especially in postmenopausal women. In
Tzu‐Yu Huang +5 more
wiley +1 more source
The 5th edition of the European Code Against Cancer (ECAC5) contains 14 recommendations on cancer prevention. Here, we update the cancer prevention recommendations regarding the use of hormone replacement therapy (HRT), which is positioned as recommendation number 13 of the ECAC5.
Mangesh A. Thorat +18 more
wiley +1 more source
SMOKING IMPACTS HELICOBACTER PYLORI ERADICATION: RESULTS FROM A BRAZILIAN UNIVERSITY HOSPITAL. [PDF]
Fonte AACFRD +5 more
europepmc +1 more source
Evidence of novel pathogenic pathways for the formation of antigastric autoantibodies in Helicobacter pylori gastritis. [PDF]
Gerhard Faller +3 more
openalex +1 more source
European Code Against Cancer, 5th edition – cancer‐causing infections and related interventions
The 5th edition of the European Code Against Cancer (ECAC5) contains 14 recommendations on cancer prevention. Here, we update the cancer prevention recommendations related to cancer‐causing infections, namely H. pylori, HPV, HBV, HCV and HIV, positioned as recommendation number 12.
Catharina Johanna Alberts +18 more
wiley +1 more source
European Code Against Cancer, 5th edition – organised cancer screening programmes
ECAC5 updates cancer prevention recommendations on cancer screening. Individuals are recommended to take part in organised screening programmes for colorectal, breast, cervical and lung cancer, as recommended in their country. Policymakers should aim to implement sustainable, organised screening programmes for these cancer types to facilitate their ...
Esther Toes‐Zoutendijk +19 more
wiley +1 more source
<i>Helicobacter pylori</i> Eradication: Why Recurrence Risk Should Not Dictate Treatment Decisions. [PDF]
Chen X +5 more
europepmc +1 more source

